{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:30:19Z","timestamp":1789979419530,"version":"4.0.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Special Programme for Research and Training in Tropical Diseases\/World Health Organization","award":["B40396"],"award-info":[{"award-number":["B40396"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200810","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T17:26:35Z","timestamp":1534958795000},"page":"e0200810","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV\/AIDS, Tuberculosis and Malaria: A prospective cohort study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-8576","authenticated-orcid":true,"given":"Yohanna Kambai","family":"Avong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolajoko","family":"Jatau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritmwa","family":"Gurumnaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfwang","family":"Danat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istifanus","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Mordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing","family":"Ukpabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga Ayodele","family":"Kayode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswata","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"El-Tayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bamgboye","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isah","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oche","family":"Agbaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Osakwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Ogar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Nosiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice B.","family":"Avong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Adekanmbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alash\u2019le","family":"Abimiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetunde O.","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Olalekan","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dakum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamau Edward","family":"Mberu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumide A. T.","family":"Ogundahunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"issue":"2","key":"ref1","first-page":"46","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies","volume":"24","author":"HJ Beijer","year":"2002","journal-title":"PharmWorld Sci"},{"issue":"7\u20138","key":"ref2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/106002809302700702","article-title":"Drug-related hospital admissions","volume":"27","author":"TR Einarson","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1L037","article-title":"Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies","volume":"42","author":"C Kongkaew","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"15","key":"ref4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"J Lazarou","year":"1998","journal-title":"JAMA"},{"issue":"7456","key":"ref5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"M Pirmohamed","year":"2004","journal-title":"BMJ"},{"issue":"35","key":"ref6","first-page":"2338","article-title":"Adverse drug reactions a common cause of hospitalization of the elderly. A clinical retrospective study","volume":"105","author":"E Paul","year":"2008","journal-title":"Lakartidningen"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1503\/cmaj.1040498","article-title":"The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada","volume":"170","author":"GR Baker","year":"2004","journal-title":"CMAJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.socscimed.2011.11.046","article-title":"Pharmacovigilance in Europe and North America: divergent approaches","volume":"75","author":"M Wiktorowicz","year":"2012","journal-title":"Soc Sci Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e010568","DOI":"10.1136\/bmjopen-2015-010568","article-title":"Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients","volume":"7","author":"R Kiguba","year":"2017","journal-title":"BMJ open"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970\u20132002","volume":"294","author":"A Jemal","year":"2005","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/ije\/dyt198","article-title":"Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis","volume":"42","author":"DG Dillon","year":"2013","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","article-title":"Diabetes in sub-Saharan Africa","volume":"375","author":"JC Mbanya","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"e0120161","DOI":"10.1371\/journal.pone.0120161","article-title":"Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria","volume":"10","author":"YK Avong","year":"2015","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"L Hazell","year":"2006","journal-title":"Drug Saf"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1590\/S0080-623420140000400023","article-title":"Causes for the under-reporting of adverse drug events by health professionals: a systematic review","volume":"48","author":"FR Varallo","year":"2014","journal-title":"Rev Esc Enferm USP"},{"key":"ref16","first-page":"433","article-title":"Attitudes to adverse drug-reaction reporting","volume":"41","author":"WHW Inman","year":"1996","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pds.897","article-title":"Pharmacists\u2019 role in reporting adverse drug reactions in an international perspective","volume":"13","author":"K van Grootheest","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/009286158602000207","article-title":"Factors affecting physician reporting of adverse drug reactions","volume":"20","author":"JB Milstien","year":"1986","journal-title":"Drug Inf J"},{"key":"ref19","first-page":"195","article-title":"The attitudes of general practitioners to monitoring and reporting adverse drug reactions","volume":"1","author":"SR Walker","year":"1986","journal-title":"Pharm Med"},{"key":"ref20","first-page":"131","article-title":"Attitudes to adverse drug reactions and their reporting among medical practitioners","volume":"72","author":"AH Robins","year":"1987","journal-title":"S Afr Med J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archinte.1988.00380070090021","article-title":"Physician knowledge, attitudes, and behavior related to reporting adverse drug events","volume":"148","author":"AS Rogers","year":"1988","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.1990.03440130073028","article-title":"Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project","volume":"263","author":"HD Scott","year":"1990","journal-title":"JAMA"},{"key":"ref23","first-page":"117","article-title":"Hospital and nursing home pharmacists\u2019 attitudes toward adverse drug reaction reporting","volume":"7","author":"JE Fincham","year":"1990","journal-title":"J Soc Admin Pharm"},{"key":"ref24","first-page":"421","article-title":"Attitudes to adverse drug reaction reporting in the northern region","volume":"34","author":"DN Bateman","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/106002809402801213","article-title":"Pharmacists\u2019 attitudes toward adverse drug reaction reporting in Hong Kong","volume":"28","author":"KK Lee","year":"1994","journal-title":"Ann Pharmacother"},{"key":"ref26","first-page":"1692","article-title":"Attitude and considerations of Danish physicians towards reporting of adverse drug reactions: a questionnaire study under European direction","volume":"157","author":"LF Gram","year":"1995","journal-title":"Ugeskr Laeger"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2125.1995.tb04440.x","article-title":"Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom","volume":"39","author":"KJ Belton","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/106002809502900404","article-title":"Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists","volume":"29","author":"JA Generali","year":"1995","journal-title":"Ann Pharmacother"},{"issue":"5","key":"ref29","first-page":"459","article-title":"Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyr\u00e9n\u00e9es region Therapie","volume":"50","author":"P Pouget-Zago","year":"1995"},{"key":"ref30","first-page":"1","article-title":"Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis","author":"A Terblanche","year":"2017","journal-title":"Hosp Pract"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JRS-130605","article-title":"Impact of training on Nigerian healthcare professionals&apos; knowledge and practice of pharmacovigilance","volume":"25","author":"A Osakwe","year":"2013","journal-title":"Int J Risk Saf Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","article-title":"Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions","volume":"165","author":"DK Wysowski","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/17512433.1.5.695","article-title":"Clinical perspective in drug safety and adverse drug reactions","volume":"1","author":"PI Pillars","year":"2008","journal-title":"Expert Rev Clinical Pharmacology"},{"key":"ref34","unstructured":"British Broadcasting Corporation World Service. What happened to Thalidomide babies? Report by Frederick Dove, 3rd Nov. 2011. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bbc.com\/news\/magazine-15536544\" xlink:type=\"simple\">http:\/\/www.bbc.com\/news\/magazine-15536544<\/ext-link>. Accessed on 3rd Jul 2017."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13256-016-0876-9","article-title":"A 33-year-old patient with humanimmunodeficiency virus on antiretroviral therapy with efavirenz-induced complex partial seizures: a case report","volume":"10","author":"NY Shehu","year":"2016","journal-title":"J Med Case Reports"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.9734\/BJPR\/2014\/6520","article-title":"Adverse drug reaction reports in an antiretroviral treatment centre in Jos, North Central Nigeria","volume":"4","author":"LO Ogwuche","year":"2014","journal-title":"Br J Pharmac Res"},{"issue":"11","key":"ref37","first-page":"1221","article-title":"Efavirenz-induced gynaecomastia in HIV-infected Nigerian men: A report of six cases","volume":"2","author":"OA Agbaji","year":"2011","journal-title":"Journal of Medicine and Medical Sciences"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/2229-3485.111784","article-title":"Adverse drug reactions to antiretroviral therapy: results from spontaneous reporting system in Nigeria","volume":"4","author":"KA Agu","year":"2013","journal-title":"Perspectives in Clinical Research"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"JR Koethe","year":"2016","journal-title":"AID Res Hum Retroviruses"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","article-title":"Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection","volume":"4","author":"G Barbaro","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref41","first-page":"2","year":"2008"},{"key":"ref42","first-page":"183","author":"PC Waller","year":"2002"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40264-013-0131-x","article-title":"vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues","volume":"37","author":"T Bergvall","year":"2014","journal-title":"Drug Saf"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00002018-200629020-00008","article-title":"An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets","volume":"29","author":"A Clarke","year":"2006","journal-title":"Drug Saf"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0140-6736(90)91669-2","article-title":"Quality criteria for early signals of possible adverse drug reactions","volume":"336","author":"IR Edwards","year":"1990","journal-title":"Lancet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2165\/00002018-200427120-00003","article-title":"Data quality management in pharmacovigilance","volume":"27","author":"M Lindquist","year":"2004","journal-title":"Drug Saf"},{"issue":"2","key":"ref47","first-page":"31","article-title":"Heath workers and hospital patients\u2019 knowledge of pharmacovigilance in Sokoto, North-West, Nigeria","volume":"11","author":"JU Chinenye","year":"2012","journal-title":"Nig J Pharmac Sci"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4314\/tjpr.v10i3.4","article-title":"Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting among Healthcare Workers in a Tertiary Centre in Northern Nigeria","volume":"10","author":"JO Fadare","year":"2011","journal-title":"Tropical Journal of Pharmaceutical Research"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pds.1724","article-title":"Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria","volume":"19","author":"JO Ohaju-Obodo","year":"2010","journal-title":"Pharmacoepidemiology Drug Safety"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pds.2021","article-title":"The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria","volume":"20","author":"IA Oreagba","year":"2011","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"ref51","unstructured":"Speech of the Acting Director of the National Agency for Food and Drug Administration and Control, delivered on the 3rd March, 2016 in Abuja during the occasion of declaring the SPHAR-TI Workshop opened."},{"key":"ref52","unstructured":"The importance of pharmacovigilance: safety monitoring of medicinal products. WHO-UMC 2002."},{"key":"ref53","unstructured":"Nigeria Federal Ministry of Health. Health Workforce Country Profile for Nigeria, First Edition. October 2008. Abuja: FMOH. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.afro.who.int\/index.php?option=com_docman&task=doc_download\" xlink:type=\"simple\">http:\/\/www.afro.who.int\/index.php?option=com_docman&amp;task=doc_download<\/ext-link>. Accessed on 2nd July 2017"},{"issue":"1","key":"ref54","first-page":"9","article-title":"Health Workforce for 2016\u20132030: Will Nigeria have enough?","volume":"4","author":"O Adebayo","year":"2016","journal-title":"Inter J Inn Heal Res"},{"key":"ref55","unstructured":"World Health Organization. \u201cThe world health report: 2006: working together for health\u201d"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-4491-1-3","article-title":"Monitoring and evaluation of human resources for health: an international perspective","volume":"1","author":"K Diallo","year":"2003","journal-title":"Human resources for health"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5588\/pha.14.0011","article-title":"The Structured Operational Research and Training Initiative for public health programs","volume":"4","author":"A Ramsay","year":"2014","journal-title":"Public Health Action"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5588\/pha.16.0057","article-title":"Sustained research capacity after completing a Structured Operational Research and Training (SORT IT) course","volume":"6","author":"N Guillerm","year":"2016","journal-title":"Public Health Action"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","article-title":"Determinants of under-reporting of adverse drug reactions: a systematic review","volume":"32","author":"E Lopez-Gonzalez","year":"2009","journal-title":"Drug Saf"},{"issue":"2","key":"ref60","first-page":"e262","article-title":"Lifelong ART for 20 million people in sub-Saharan Africa: communities will be key for success","author":"DN Ford","year":"2014","journal-title":"The Lancet Global Health"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"FJ Palella Jr","year":"2006","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study","volume":"14","author":"R Weber","year":"2013","journal-title":"HIV medicine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/QCO.0b013e32834ef586","article-title":"Neurocognitive dysfunction in the highly active antiretroviral therapy era","volume":"25","author":"NZ Mothobi","year":"2012","journal-title":"Current opinion in infectious diseases"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e59768","DOI":"10.1371\/journal.pone.0059768","article-title":"Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era","volume":"8","author":"B Grinsztejn","year":"2013","journal-title":"PloS One"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8603-5-9","article-title":"A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization","volume":"5","author":"F Young","year":"2009","journal-title":"Global Health"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40360-015-0036-7","article-title":"Comparing amikacin and kanamycininduced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort","volume":"16","author":"EL Sagwa","year":"2015","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/1119-3077.104527","article-title":"Prevalence of ototoxicity in University of Benin Teaching Hospital, Benin city: a 5-year review","volume":"15","author":"G Obasikene","year":"2012","journal-title":"Niger J Clin Pract"},{"issue":"7497","key":"ref68","first-page":"927","article-title":"Developed world is robbing African countries of health staff","volume":"330","author":"Rebecca Coombes","year":"2005","journal-title":"Br Med J"},{"key":"ref69","unstructured":"World Health Organization. Research for universal health coverage: World Health Organization report 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/whr\/2013\/report\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/whr\/2013\/report\/en\/<\/ext-link>. Accessed on 1st\/07\/2017."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T03:42:11Z","timestamp":1604806931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200810"}},"subtitle":[],"editor":[{"given":"Albert","family":"Figueras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200810","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]}}}